Heart rate decrease during crizotinib treatment and potential correlation to clinical response
Ou, Sai‐Hong Ignatius, Tong, Wilson P., Azada, Michele, Siwak‐Tapp, Christina, Dy, Joni, Stiber, Jonathan A.
Published in Cancer (01.06.2013)
Published in Cancer (01.06.2013)
Get full text
Journal Article
Region specific neuron loss in the aged canine hippocampus is reduced by enrichment
Siwak-Tapp, Christina T, Head, Elizabeth, Muggenburg, Bruce A, Milgram, Norton W, Cotman, Carl W
Published in Neurobiology of aging (01.01.2008)
Published in Neurobiology of aging (01.01.2008)
Get full text
Journal Article
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
BERGETHON, Kristin, SHAW, Alice T, MARK, Eugene J, BATTEN, Julie M, HAIQUAN CHEN, WILNER, Keith D, KWAK, Eunice L, CLARK, Jeffrey W, CARBONE, David P, HONGBIN JI, ENGELMAN, Jeffrey A, MINO-KENUDSON, Mari, IGNATIUS OU, Sai-Hong, PAO, William, IAFRATE, A. John, KATAYAMA, Ryohei, LOVLY, Christine M, MCDONALD, Nerina T, MASSION, Pierre P, SIWAK-TAPP, Christina, GONZALEZ, Adriana, RONG FANG
Published in Journal of clinical oncology (10.03.2012)
Published in Journal of clinical oncology (10.03.2012)
Get full text
Journal Article
Next-Generation Sequencing Reveals a Novel NSCLC ALK F1174V Mutation and Confirms ALK G1202R Mutation Confers High-Level Resistance to Alectinib (CH5424802/RO5424802) in ALK-Rearranged NSCLC Patients Who Progressed on Crizotinib
Ou, Sai-Hong Ignatius, Azada, Michele, Hsiang, David J., Herman, June M., Kain, Tatiana S., Siwak-Tapp, Christina, Casey, Cameron, He, Jie, Ali, Siraj M., Klempner, Samuel J., Miller, Vincent A.
Published in Journal of thoracic oncology (01.04.2014)
Published in Journal of thoracic oncology (01.04.2014)
Get full text
Journal Article
Neuroprotective effects of cognitive enrichment
Milgram, Norton W, Siwak-Tapp, Christina T, Araujo, Joseph, Head, Elizabeth
Published in Ageing research reviews (01.08.2006)
Published in Ageing research reviews (01.08.2006)
Get full text
Journal Article
Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
Ou, Sai-Hong Ignatius, Kwak, Eunice L., Siwak-Tapp, Christina, Dy, Joni, Bergethon, Kristin, Clark, Jeffrey W., Camidge, D. Ross, Solomon, Benjamin J., Maki, Robert G., Bang, Yung-Jue, Kim, Dong-Wan, Christensen, James, Tan, Weiwei, Wilner, Keith D., Salgia, Ravi, Iafrate, A. John
Published in Journal of thoracic oncology (01.05.2011)
Published in Journal of thoracic oncology (01.05.2011)
Get full text
Journal Article